Comparative Effectiveness Bill Calls For Private Group To Plan Research
Executive Summary
While getting little exposure in the new Medicare law, comparative effectiveness research is getting full attention in a bill introduced by Sen. Max Baucus, D-Mont., that offers a comprehensive roadmap toward conducting the research and disseminating findings
You may also be interested in...
Baucus Takes “Patient-Centered” Focus For Comparative Effectiveness In Bill
The changes Sen. Max Baucus made in a reintroduced comparative effectiveness bill may be small compared to the 2008 version, but they suggest a different focus that might be a more welcome approach by the pharma industry
Baucus Takes “Patient-Centered” Focus For Comparative Effectiveness In Bill
The changes Sen. Max Baucus made in a reintroduced comparative effectiveness bill may be small compared to the 2008 version, but they suggest a different focus that might be a more welcome approach by the pharma industry
PhRMA, Others Look For Savings In Reduced Drug Interactions
Reducing the instances of adverse events related to drug-drug interactions is among the options to reduce health care spending presented by both the Pharmaceutical Research and Manufacturers of America and the American Medical Association
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: